Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal decision profile

Clinical Microbiology Reviews

Biochemistry, Genetics and Molecular Biology · Medicine
American Society for MicrobiologyUnited StatespISSN 0893-8512eISSN 1098-6618
Checking system sharing availability.Visit homepage
Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
16.8

Journal Metrics Score 2026 · 20212024 window citedness 21.77.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED

Not available — there are not enough recent PubMed records with both received and accepted dates.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
Not available

No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
16.82026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#105 / 698LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
81.4%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
7.21MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
NOT AVAILABLE
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
40 / yr2021–2024 AVG
Field-normalized top 10% share81.4%

131 of 161 works · same type, year & subfield

Field-normalized top 1% share35.4%

57 works · same type, year & subfield

Median FWCI7.21×

Above field-year expectation

Source output rank#105

of 698 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 7.21, so its typical recent paper runs about 621% above its field benchmark.

What does Top 10% Share mean?

81.4% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 20162025

442016
452017
382018
462019
432020
432021
332022
272023
582024
622025

Recent work-type mix

161 OpenAlex works · 20212024

Article88.8%
Paratext5%
Erratum2.5%
Editorial1.9%
Review1.9%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works
COVID-19Anti-Bacterial AgentsHIV InfectionsSARS-CoV-2Communicable DiseasesGastrointestinal MicrobiomeRespiratory Tract InfectionsAnti-Infective AgentsAntifungal Agents

Leading OpenAlex topics

20212024 works
Antibiotic Resistance in Bacteria11
Antifungal resistance and susceptibility8
Diverse Scientific and Economic Studies8
Bacterial Identification and Susceptibility Testing6
SARS-CoV-2 and COVID-19 Research6
Antimicrobial Resistance in Staphylococcus5
SARS-CoV-2 detection and testing5
Bacterial Infections and Vaccines4
Bacteriophages and microbial interactions4
COVID-19 Clinical Research Studies4
Methodology: OpenAlex snapshot 2026-08-12. FWCI, percentile badges, topics, and type mix use 161 works published 20212024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Clinical BiochemistryQ1
Molecular MedicineQ1
Infectious DiseasesQ1

Considering submitting to Clinical Microbiology Reviews?

Use your manuscript title to find AI-ranked journals with related recent work, fit reasons, risks, and submission strategy.

Match my manuscript →
Q1
Subfield Quartile
B1
CAS Block

Ranking and source check

#34
of 6,254 Medicine field journals
#34
among Q1 Medicine journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
1,863
H-Index
421
Fully Open Access
No
Recent OA Works
1,588
Subject Areas
Clinical BiochemistryMolecular MedicineInfectious DiseasesInfectious Diseases

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

Back to Search